Exit Notice
You are about to leave ClinicalTrials.gov and go to: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer URL: http://www.ncbi.nlm.nih.gov/pubmed/31851799
Click on the link to continue or return to ClinicalTrials.gov Home